Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Tenon Medical (TNON) Gross Profit (2021 - 2025)

Tenon Medical has reported Gross Profit over the past 5 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 188.1% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $2.4 million, up 37.81%, while the annual FY2025 figure was $2.4 million, 37.81% up from the prior year.
  • Gross Profit for Q4 2025 was $1.0 million at Tenon Medical, up from $773000.0 in the prior quarter.
  • Over five years, Gross Profit peaked at $1.0 million in Q4 2025 and troughed at -$207000.0 in Q4 2022.
  • A 5-year average of $238700.0 and a median of $219500.0 in 2023 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: tumbled 5200.0% in 2022 and later soared 1100.0% in 2024.
  • Year by year, Gross Profit stood at $36000.0 in 2021, then tumbled by 675.0% to -$207000.0 in 2022, then soared by 370.05% to $559000.0 in 2023, then tumbled by 36.85% to $353000.0 in 2024, then surged by 188.1% to $1.0 million in 2025.
  • Business Quant data shows Gross Profit for TNON at $1.0 million in Q4 2025, $773000.0 in Q3 2025, and $245000.0 in Q2 2025.